Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...
We argue against selling Geron at current prices, citing strong market potential of imetelstat and Royalty Pharma deal valuation. Read more on GERN stock here.
By Dr. Mike Walden North Carolina has gone through two major economic overhauls in the last 150 years. The first was the shift from a largely agrarian economy to an economy focused on manufacturing ...
If implemented, this initiative could be a game-changer. Industry insiders estimate that Bangladesh could save $1 billion in foreign currency annually by reducing its reliance on imported APIs ...